Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Inspira Technologies Oxy
(NASDAQ:IINN)
Intraday
$2.10
-0.01
[-0.47%]
After-Hours
$2.10
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.10
-0.01
[-0.47%]
At close: May 14
$2.10
0
[0.00%]
After Hours: 4:04PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Inspira Technologies Oxy Stock (NASDAQ:IINN)
Inspira Technologies Oxy Stock (NASDAQ: IINN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, May 02, 2024
Inspira Announces Start Of Production Of The INSPIRA ART100 Medical Device
Benzinga Newsdesk
-
May 2, 2024, 9:18AM
Thursday, April 25, 2024
Inspira Receives CSA Certification Of Compliance To U.S. Standards For The INSPIRA ART100
Benzinga Newsdesk
-
Apr 25, 2024, 8:04AM
Tuesday, April 16, 2024
Inspira Technologies Signs Term Sheet With Beilinson Hospital For The Evaluation Of Its INSPIRA ART100 Device In Organ Transplant Procedures
Benzinga Newsdesk
-
Apr 16, 2024, 8:43AM
Wednesday, April 10, 2024
Inspira And Ennocure Announced Results From Collaborative Development Of Proprietary Bio-Electronic Treatment To Prevent Associated Bloodstream Infections In Patients In Intensive Care Units
Benzinga Newsdesk
-
Apr 10, 2024, 8:25AM
Monday, March 25, 2024
Inspira Technologies Oxy Q4 EPS $(0.27) Beats $(0.30) Estimate
Happy Mohamed
-
Mar 25, 2024, 9:40AM
Inspira Technologies FY23 Cash And Cash Equivalents $7.361M
Benzinga Newsdesk
-
Mar 25, 2024, 9:25AM
Monday, March 18, 2024
Inspira Technologies OXY Announces Israel's AMAR Submission For Approval Of INSPIRA ART100, Marking A Significant Milestone In Inspira's Venture Into New Markets
Benzinga Newsdesk
-
Mar 18, 2024, 7:02AM
Tuesday, March 12, 2024
Inspira Releases New Data Demonstrating Superiority Of Its Core Technology, Across Key Endpoints Of HMSS Indicator
Happy Mohamed
-
Mar 12, 2024, 8:13AM
Tuesday, February 27, 2024
Inspira Nears First FDA 510(K) Approval, 3 US Patents Approved, $546M in Summary Distribution Agreements
Benzinga Newsdesk
-
Feb 27, 2024, 7:15AM
Thursday, February 22, 2024
Inspira Technologies Has Unveiled An Exclusive In-house Capability Designed To Simulate Both The Arterial And Venous Blood Parameters Of Patients With Specific Medical Conditions Without The Need Of In Vivo Animal Testing
Benzinga Newsdesk
-
Feb 22, 2024, 7:05AM
Thursday, February 15, 2024
What's Going On With Inspira Technologies (IINN) Shares?
Henry Khederian
-
Feb 15, 2024, 11:37AM
Wednesday, February 14, 2024
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Feb 14, 2024, 1:18PM
Why Inspira Technologies (IINN) Stock Is Popping Off
Henry Khederian
-
Feb 14, 2024, 9:01AM
Inspira Technologies shares are trading higher after the company announced it received the first ever U.S. Patent approval for an orbiting blood oxygenation delivery system, a core technology of the INSPIRA ART500 device.
Benzinga Newsdesk
-
Feb 14, 2024, 8:56AM
Market-Moving News for February 14th
Benzinga Newsdesk
-
Feb 14, 2024, 8:37AM
Inspira Receives First Ever US Patent Approval For An Orbiting Blood Oxygenation Delivery System, A Core Technology Of INSPIRA ART500 Device
Benzinga Newsdesk
-
Feb 14, 2024, 7:33AM
Thursday, February 08, 2024
Inspira Technologies Collaborates With A Leading Israeli Medical Center For Clinical Evaluation Of INSPIRA ART Device
Benzinga Newsdesk
-
Feb 8, 2024, 9:08AM
Tuesday, January 30, 2024
Inspira Technologies Announces Summary Distribution Agreement With Glo-Med Networks
Benzinga Newsdesk
-
Jan 30, 2024, 8:37AM
Tuesday, January 09, 2024
Inspira Announces Plans To Launch And Target Single-Use Disposable Blood Oxygenation Kit For A New Disposable Perfusion Market Opportunity; The Kit, Anticipated To Be Submitted For U.S. FDA Authorization In 2025
Benzinga Newsdesk
-
Jan 9, 2024, 8:42AM
Tuesday, January 02, 2024
Inspira Technologies Signs Letter Of Intent With Northwestern Memorial Hospital In Chicago For Clinical Use Of INSPIRA ART100 Device
Benzinga Newsdesk
-
Jan 2, 2024, 8:37AM
Wednesday, December 27, 2023
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Dec 27, 2023, 2:11PM
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Dec 27, 2023, 8:14AM
Tuesday, December 26, 2023
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
Avi Kapoor
-
Dec 26, 2023, 2:43PM
Inspira Announces $3.88M Registered Direct Offering Of 3,031,250 Shares At $1.28/Share
Benzinga Newsdesk
-
Dec 26, 2023, 2:20PM
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Dec 26, 2023, 1:48PM
Crude Oil Rises Over 3%; US Home Prices Increase In October
Avi Kapoor
-
Dec 26, 2023, 12:20PM
Inspira Technologies shares are trading higher after the company announced 95% accuracy results for HYLA Blood Sensor. Additionally, the company plans FDA submission for clearance in 2024.
Benzinga Newsdesk
-
Dec 26, 2023, 11:00AM
Why Is Respiratory Care Device Provider Inspira Technologies Stock Surging Today?
Vandana Singh
-
Dec 26, 2023, 10:37AM
Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
Avi Kapoor
-
Dec 26, 2023, 9:39AM
Inspira Announces 95% Accuracy Results For HYLA Blood Sensor, Planning FDA Submission For Clearance In 2024
Happy Mohamed
-
Dec 26, 2023, 8:46AM
Monday, December 11, 2023
Inspira Has Appointed Dr. Dan Gorfil To Medical Advisory Board
Benzinga Newsdesk
-
Dec 11, 2023, 9:10AM
Wednesday, November 29, 2023
Inspira Collaborates With Ennocure For Development Of A Proprietary Bio-Electronic Treatment To Prevent Associated Bloodstream Infections In ICU Patients
Benzinga Newsdesk
-
Nov 29, 2023, 9:08AM
Thursday, November 16, 2023
Inspira Technologies Oxy Q3 2023 Cash, Cash Equivalents $6.39M
Benzinga Newsdesk
-
Nov 16, 2023, 9:42AM
Monday, November 06, 2023
Inspira Announces Israeli Innovation Authority Grant For New VORTX Disposable Blood Oxygenation Technology; Inspira's VORTX Is As A Potential Frontrunner In The $4B Disposable Blood Oxygenator Market
Benzinga Newsdesk
-
Nov 6, 2023, 9:05AM
Wednesday, October 25, 2023
Inspira Granted U.S. Patent For INSPIRA ART500 Medical Device
Benzinga Newsdesk
-
Oct 25, 2023, 7:50AM
Tuesday, October 10, 2023
Inspira Enters Distribution Agreement In Central America With CIO MED GROUP; Sats Agreement To Potentially Generate $28M
Bill Haddad
-
Oct 10, 2023, 9:31AM
Thursday, September 28, 2023
Inspira Technologies Unveils The INSPIRA ART Line Of Medical Devices At The World's Largest Extracorporeal Life Support Conference
Benzinga Newsdesk
-
Sep 28, 2023, 8:34AM
Wednesday, September 13, 2023
Inspira Announces 510(k) FDA Submission of INSPIRA ART100 Towards Commercialization
Benzinga Newsdesk
-
Sep 13, 2023, 8:32AM
Tuesday, August 29, 2023
Inspira Signs Agreement Expansion With Innovimed For Clinical Trials Of INSPIRA ART Respiratory Medical Devices
Happy Mohamed
-
Aug 29, 2023, 9:37AM
Thursday, August 10, 2023
Inspira Technologies Reports Q2 2023 Financial Results; As Of June 30, 2023, The Company Had $8.9M In Cash, Cash Equivalents And Short-Term Bank Deposits
Happy Mohamed
-
Aug 10, 2023, 9:12AM
Monday, July 24, 2023
Inspira Technologies Receives Certification Of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory Approval
Happy Mohamed
-
Jul 24, 2023, 9:18AM
Wednesday, July 19, 2023
Inspira Technologies Enters Into Collaboration Agreement With U.S.-Based Perfusion Solution Inc.; Collaboration Involves Combining The INSPIRA ART100 Product With Perfusion Solution's Broad Commercial Footprint And Infrastructure Across The U.S.
Happy Mohamed
-
Jul 19, 2023, 8:05AM
Monday, June 12, 2023
Inspira Technologies Aims To Become The Tesla Of MedTech – A Glimpse Into Their Pipeline
Julian Richard
-
Sponsored
Thursday, May 18, 2023
Inspira Technologies Oxy Q4 Net Loss $3M
Benzinga Newsdesk
-
May 18, 2023, 9:31AM
Thursday, May 11, 2023
Inspira Technologies Is Developing The VORTX Blood Oxygenator, A Unique Technology For Saturating Blood With Oxygen And Removing Carbon Dioxide
Happy Mohamed
-
May 11, 2023, 9:06AM
Tuesday, April 04, 2023
Inspira Technologies Says Entered Sales Agreement With Roth Capital Partners Relating To Sale Of Ordinary Shares; Co. May Offer, Sell Ordinary Shares Of Up To $5.5M From Time To Time
Michael Horton
-
Apr 4, 2023, 4:52PM
Inspira Technologies Reports Q4 2022 And FY Financial Results; As Of December 31, 2022, The Company Had $13.9M In Cash, Cash Equivalents, And Deposits
Happy Mohamed
-
Apr 4, 2023, 9:33AM
Wednesday, March 22, 2023
Inspira Technologies Announces First In Human Of HYLA Blood Sensor In Clinical Study
Happy Mohamed
-
Mar 22, 2023, 8:43AM
Monday, February 13, 2023
Inspira Receives Approval From Sheba Medical Center To Conduct Study Of HYLA Blood Sensor
Benzinga Newsdesk
-
Feb 13, 2023, 9:31AM
Wednesday, January 25, 2023
Aegis Capital Maintains Buy on Inspira Technologies Oxy, Raises Price Target to $13
Benzinga Newsdesk
-
Jan 25, 2023, 11:34AM
Show more